Cornelissen Bart Jan — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Cornelissen Bart Jan is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $71K.
Profile
Bart Jan Cornelissen is a financial executive known for his role as Senior Vice President and Chief Financial Officer at Xencor Inc, a biotechnology company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. He has a background in finance and has held various leadership positions in the biotech and pharmaceutical sectors.
Bart Jan Cornelissen is a financial executive known for his role as Senior Vice President and Chief Financial Officer at Xencor Inc, a biotechnology company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. He has a background in finance and has held various leadership positions in the biotech and pharmaceutical sectors.…
Has Cornelissen Bart Jan been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($71K) across all tracked filings.
Where can I see all of Cornelissen Bart Jan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
